lysergic acid diethylamide has been researched along with Abnormality, Heart in 4 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pilapil, VR | 1 |
Harp, RA | 1 |
Ehrhardt, OE | 1 |
Jacobson, CB | 1 |
Berlin, CM | 1 |
Brown, R | 1 |
Pickering, D | 1 |
4 other studies available for lysergic acid diethylamide and Abnormality, Heart
Article | Year |
---|---|
LSD and cyanotic congenital heart disease.
Topics: Abnormalities, Drug-Induced; Cyanosis; Female; Heart Defects, Congenital; Humans; Infant, Newborn; L | 1973 |
Possible reproductive detriment in LSD users.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Abortion, Therapeutic; Chromosome Aberrations; D | 1972 |
Persistent transitional circulation.
Topics: Adult; Cannabis; Cardiac Catheterization; Cyanosis; Diagnosis, Differential; Ductus Arteriosus; Duct | 1974 |
Report of Inter-Society Commission for Heart Disease Resources. Prevention of Cardiovascular Disease. Primary prevention of congenital heart disease.
Topics: Child; Chromosome Aberrations; Female; Fetal Death; Heart Defects, Congenital; Humans; Infant; Infan | 1970 |